Literature DB >> 26961565

A discrepancy between plasma glycated albumin and HbA1c levels in a patient with steroid-induced diabetes mellitus.

Katsumi Iizuka1, Takehiro Kato2, Masami Mizuno1, Jun Takeda1.   

Abstract

A 57-year-old man was admitted for the treatment of steroid-induced diabetes mellitus (DM). He also had interstitial pneumonia and, to treat it, 20 mg prednisolone had been started in April 2014. Although glycated haemoglobin (HbA1c) level was 7.8% (62 mmol/mol), his glycated albumin (GA) level was normal (13.9%) and the ratio of GA to HbA1c (GA:HbA1c) was lower than that of normal participants and patients with type 2 DM. Plasma GA and GA:HbA1c levels became persistently lower. In September 2015, HbA1c levels measured by HPLC and immunoprecipitation methods were almost the same (6.8% (51 mmol/mol) and 6.7% (50 mmol/mol), respectively), but GA (10.2%) and GA:HbA1c (1.6) were much lower. We report the case of a patient with DM where steroid administration may have caused a decrease in plasma GA and GA:HbA1c levels via increased albumin turnover. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26961565      PMCID: PMC4785422          DOI: 10.1136/bcr-2016-214788

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  The effects of adrenocortical hormones on albumin metabolism studied with albumin-I 131.

Authors:  M A ROTHSCHILD; S S SCHREIBER; M ORATZ; H L McGEE
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

2.  A case of type 2 diabetes mellitus developing hypothyroidism discovered as a result of a discrepancy between glycated hemoglobin and glycated albumin values.

Authors:  Kenji Moriyama; Naotetsu Kanamoto; Yuji Hataya; Takuo Nanbu; Kiminori Hosoda; Hiroshi Arai; Kazuwa Nakao
Journal:  Diabetes Res Clin Pract       Date:  2005-08-19       Impact factor: 5.602

3.  Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease.

Authors:  Yukihiro Bando; Hideo Kanehara; Daisyu Toya; Nobuyoshi Tanaka; Soji Kasayama; Masafumi Koga
Journal:  Ann Clin Biochem       Date:  2009-08-12       Impact factor: 2.057

4.  Glycosylation of serum albumin: elevated glycosyl-albumin in diabetic patients.

Authors:  R Dolhofer; O H Wieland
Journal:  FEBS Lett       Date:  1979-07-15       Impact factor: 4.124

5.  Specific glycation of albumin depends on its half-life.

Authors:  E D Schleicher; B Olgemöller; E Wiedenmann; K D Gerbitz
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

Review 6.  Serum albumin: relationship to inflammation and nutrition.

Authors:  Burl R Don; George Kaysen
Journal:  Semin Dial       Date:  2004 Nov-Dec       Impact factor: 3.455

7.  Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome.

Authors:  Tetsuhiro Kitamura; Michio Otsuki; Daisuke Tamada; Yukiko Tabuchi; Kosuke Mukai; Shinya Morita; Soji Kasayama; Iichiro Shimomura; Masafumi Koga
Journal:  Clin Chim Acta       Date:  2013-06-18       Impact factor: 3.786

Review 8.  Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.

Authors:  Ji-Eun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-06-30

9.  Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus.

Authors:  C E Guthrow; M A Morris; J F Day; S R Thorpe; J W Baynes
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

10.  New indices for predicting glycaemic variability.

Authors:  Akifumi Ogawa; Akinori Hayashi; Eriko Kishihara; Sonomi Yoshino; Akihiro Takeuchi; Masayoshi Shichiri
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

View more
  1 in total

1.  High Dose Prednisolone Lowers Plasma Glycated Albumin Levels Compared to Actual Glycemic Control: A Retrospective Observational Study.

Authors:  Masami Mizuno; Katsumi Iizuka; Takuma Ishihara; Shusaku Fukaya; Shunji Yoshida; Jun Takeda
Journal:  Diabetes Ther       Date:  2018-12-13       Impact factor: 2.945

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.